Rare Inflammatory Disease Treatment Market

Rare Inflammatory Disease Treatment Market: North America will Continue to be Dominant In Terms Of Revenue through 2026: Global Industry Analysis (2012-2016) & Opportunity Assessment (2017-2026)

Ask The Analyst Customization Available Request Methodology

Innovative treatments are being developed by researchers, who are mainly focusing on reducing inflammation by using immunosuppressive therapies. Although these treatments promise remission in patients, risk of complications or relapse from long-lasting therapy prevail as key concerns. Significant improvements in the healthcare industry will stimulate in dealing with the rising instances regarding rare inflammatory diseases. Factors such as public health issues, antimicrobial resistance and unhygienic conditions are highly responsible for the prevalence of rare inflammatory disease. According to recent survey, nearly 200,000 patients suffer from more than 150 rare inflammatory diseases worldwide, which are also termed as ‘orphan diseases’. Out of these 150 orphan diseases, most of them are terminal and incurable.

Manufacturers are making heavy investments in R&D for developing new drugs for the rare inflammatory diseases. Technological advancements in equipment as well as procedures are likely to enable researchers to make improvements in diagnosing, treatment, and prevention of rare inflammatory diseases. As majority of rare diseases do not have effective treatment, researchers and pharmaceutical & medical companies are taking robust efforts toward new drug development as well as making advancements in currently employed drug formulations.  The NIH (National Institutes of Health) is also supporting towards health improvement of affected and non-affected public with rare inflammatory diseases by focusing on new treatments. These institutes are providing support through collaborative projects which would help in examining common causes and themes of related diseases.

rare inflammatory disease treatment market

According to recent report by Future Market Insights, the global market for rare inflammatory disease treatment is poised to grow at 4.4% CAGR during the review period, 2017-2026. The report evaluates that by 2026-end, around US$ 16,000 Mn rare inflammatory disease treatment products will be sold across the globe. The report additionally expects that North America will be leading the global rare inflammatory disease treatment market, in terms of revenues.

Juvenile Rheumatoid Arthritis to Gain Traction Through 2026

Juvenile rheumatoid arthritis is experienced by children at the age or less than 16years and the symptoms include stiffness, pain or tenderness on affected joints, abnormal warmth and swelling. In acute cases, critical changes may ultimately result in restricted mobility and potential deformity of concerned joints. Low prices of juvenile rheumatoid arthritis treatments will influence the producers to increase their manufacturing for advanced drugs and therapies. The report anticipates that juvenile rheumatoid arthritis will exhibit the highest CAGR over the forecast period.

Retail Pharmacies Distribution Channel of Rare Inflammatory Disease Treatment to Register Highest Value CAGR through 2017-2026

The increasing patient-centric support from retail pharmacies is leading to exceptional and consistent service levels in pharmacies. Several highly-skilled retail pharmacies are also available 24/7 in order to meet the needs of the patients. Retail pharmacies are also taking efforts in increasing availability of physicians in each pharmacy for better efficiency and to increase consumer demand. The report anticipates that by 2026-end, nearly 39.4% of rare inflammatory disease treatment expenditure will be held up by retail pharmacies across the globe.

Global Rare Inflammatory Disease Treatment Market

Companies leading the global rare inflammatory disease treatment market have been profiled by the analysts in the report. They include Novartis AG, Abbvie, Abbott Laboratories, Regeneron Pharmaceuticals, Swedish Orphan Biovitrum AB, Pfizer, Inc., Allergan Plc, Valeant, Johnson & Johnson and Questcor Pharmaceuticals, Inc. Some of these companiesare likely to cope with challenges through development of cost-effective treatments and advanced drugs. In addition, reducing production costs and raising profit margins will be a key focus area for players in the global rare inflammatory disease treatment market.

Increasing number of autoimmune & inflammatory diseases along with genetic diseases is driving the growth of global market for rare inflammatory disease treatment. Researchers are stepping up their efforts in analyzing the unsolved mechanism which is included in the pathogenesis of the developing inflammatory and infectious diseases, which also provides significant insights on their therapies. Drug development for inflammatory diseases has been taking place focusing on treating pathogenesis and symptoms of each disease individually. It is likely that the number of inflammatory bowel disease will observe an increase, and this disease is also life-threatening for patients.

Efforts have been taken for leveraging integrated commercial, operational and medical methods for inflammation study. Interconnected inflammation diseases are taken into consideration and focus is given on scientific expertise, efficiency and strategy. Identification of new agents is done in order to develop treatments for multiple inflammatory diseases, which share common pathways. Manufacturers are engaging in effective alliances which would help in facilitating movement of therapies by means of clinical progress life cycle.

Future Market Insights has prepared a report providing a detailed market analysis with the help of inputs from the industry specialists, by ensuring meaningful and robust data, with the help of effectual trial design as well as endpoint assessment. A holistic study regarding current trends in the rarely infectious diseases diagnostic and therapeutic market, advanced therapies, industry growth drivers and restraints. The report also delivers market projection for the forthcoming years. Latest technological advancements based on inflammation diseases diagnosis and treatment has also been included in the report.

This report is also includes an assessment of macro and micro factors crucial for the prevailing market players as well as new entrants together with in depth value chain analysis. The report covers present-day scenario along with growth prospects of global rare inflammatory disease treatment market for 2017-2026 period. For calculating the market size, report takes into account revenue produced from sales of several drugs utilized in the treatment of rare inflammatory diseases.

Report Synopsis

The report consists of several chapters, which will deliver an accurate data regarding the development of global market for rare inflammatory diseases treatment, for the forecast period. An exclusive synopsis abridges the significant highpoints from the wide-ranging research report and presents them thoroughly, in order to disclose primary segments, untouched markets and cost-effective growth opportunities.

The report furthermore reviews the changing facets of the global rare inflammatory disease treatment market. In this section, traits that are probable to drive and detain the sales of rare inflammatory disease treatment has also been analyzed. Revenues from topmost rare inflammatory disease treatment companies have been revealed to bring baselines for estimating the revenue growth of the global market. The report has additionally assessed the global rare inflammatory disease treatment supply chain and has shown the remarkable raw material sourcing processes performed by the market players.

Market Taxonomy

For meeting the objectives of the findings, the global rare inflammatory disease treatment market report has been segmented based on the distribution channel, drug class, mode of administration, indication, and region. As per the taxonomy detailed in the report, global market for rare inflammatory diseases treatment has been listed accordingly:

Region

Indication

Drug Class

Mode of Administration

Distribution Channel

North America

Ulcerative Colitis

Biologics

Injectables

Hospital Pharmacies

Latin America

Juvenile Rheumatoid Arthritis

Organic Compounds

Oral

Retail Pharmacies

Europe

Psoriatic Arthritis

 

Others

Online Pharmacies

Japan

Other Indications

 

 

 

APEJ

 

 

 

 

MEA

 

 

 

 

Detailed Competition Landscape

The report presents a detailed information on the vendor landscape along with a corresponding analysis related to leading vendors in the global rare inflammatory disease treatment market. The vendor landscape is inclusive of analysis on major vendors together with competitive performances related to their portfolios. The report also covers the landscape of global rare inflammatory disease treatment market and its prospects for growth in the forthcoming years.

The report includes ideas exchanged between the key vendors and analysts operating in this market. Moreover, this report provides a visual, effortlessly navigable platform, from where the client can evaluate value of their as well as competitive products. It would help the market players in generating facts and positioning strategies for difference & value optimization in a progressively competitive market.

Rare Inflammatory Disease Treatment Market Reports - Table of Contents

1. Global Economic Outlook

2. Global Rare Inflammatory Disease Treatment Market - Executive Summary

3. Global Rare Inflammatory Disease Treatment Market Overview

3.1. Introduction

3.1.1. Global Rare Inflammatory Disease Treatment Market Taxonomy

3.1.2. Global Rare Inflammatory Disease Treatment Market Definition

3.2. Global Rare Inflammatory Disease Treatment Market Size (US$ Mn) and Forecast, 2012-2026

3.2.1. Global Rare Inflammatory Disease Treatment Market Y-o-Y Growth

3.3. Global Rare Inflammatory Disease Treatment Market Dynamics

3.4. Supply Chain

3.5. Cost Structure

3.6. Pricing Analysis 

3.7. Forecast Scenario

3.8. Parent Market Overview

3.9. PEST Analysis

3.10. Porter's Five Forces Analysis

3.11. Key Regulations

3.11.1. Key Regulations - North America

3.11.2. Key Regulations - Latin America

3.11.3. Key Regulations - Europe

3.11.4. Key Regulations - Asia Pacific

3.11.5. Key Regulations - Middle East & Africa

3.12. Product Approvals in Rare Inflammatory Disease Treatment Market

3.13. Investment Feasibility Index

3.14. Market Competition Structure

3.15. Market Positioning and Behaviour Assessment

3.16. List of Distributors

3.17. Key Participants Market Presence (Intensity Map) By Region

4. Global Rare Inflammatory Disease Treatment Market Analysis and Forecast 2012-2026 

4.1. Global Rare Inflammatory Disease Treatment Market Size and Forecast By Indication, 2012-2026

4.1.1. Ulcerative Colitis Market Size and Forecast, 2012-2026

4.1.1.1. Revenue (US$ Mn) Comparison, By Region

4.1.1.2. Market Share Comparison, By Region

4.1.1.3. Y-o-Y growth Comparison, By Region

4.1.2. Juvenile Rheumatoid Arthritis Market Size and Forecast, 2012-2026

4.1.2.1. Revenue (US$ Mn) Comparison, By Region

4.1.2.2. Market Share Comparison, By Region

4.1.2.3. Y-o-Y growth Comparison, By Region

4.1.3. Psoriatic Arthritis Market Size and Forecast, 2012-2026

4.1.3.1. Revenue (US$ Mn) Comparison, By Region

4.1.3.2. Market Share Comparison, By Region

4.1.3.3. Y-o-Y growth Comparison, By Region

4.1.4. Other Indications Market Size and Forecast, 2012-2026

4.1.4.1. Revenue (US$ Mn) Comparison, By Region

4.1.4.2. Market Share Comparison, By Region

4.1.4.3. Y-o-Y growth Comparison, By Region

4.2. Global Rare Inflammatory Disease Treatment Market Size and Forecast By Drug Class, 2012-2026

4.2.1. Biologics Market Size and Forecast, 2012-2026

4.2.1.1. Revenue (US$ Mn) Comparison, By Region

4.2.1.2. Market Share Comparison, By Region

4.2.1.3. Y-o-Y growth Comparison, By Region

4.2.2. Organic Compounds Market Size and Forecast, 2012-2026

4.2.2.1. Revenue (US$ Mn) Comparison, By Region

4.2.2.2. Market Share Comparison, By Region

4.2.2.3. Y-o-Y growth Comparison, By Region

4.3. Global Rare Inflammatory Disease Treatment Market Size and Forecast By Mode of Administration, 2012-2026

4.3.1. Injectables Market Size and Forecast, 2012-2026

4.3.1.1. Revenue (US$ Mn) Comparison, By Region

4.3.1.2. Market Share Comparison, By Region

4.3.1.3. Y-o-Y growth Comparison, By Region

4.3.2. Oral Market Size and Forecast, 2012-2026

4.3.2.1. Revenue (US$ Mn) Comparison, By Region

4.3.2.2. Market Share Comparison, By Region

4.3.2.3. Y-o-Y growth Comparison, By Region

4.3.3. Others Market Size and Forecast, 2012-2026

4.3.3.1. Revenue (US$ Mn) Comparison, By Region

4.3.3.2. Market Share Comparison, By Region

4.3.3.3. Y-o-Y growth Comparison, By Region

4.4. Global Rare Inflammatory Disease Treatment Market Size and Forecast By Distribution Channel, 2012-2026

4.4.1. Hospital Pharmacies Market Size and Forecast, 2012-2026

4.4.1.1. Revenue (US$ Mn) Comparison, By Region

4.4.1.2. Market Share Comparison, By Region

4.4.1.3. Y-o-Y growth Comparison, By Region

4.4.2. Retail Pharmacies Market Size and Forecast, 2012-2026

4.4.2.1. Revenue (US$ Mn) Comparison, By Region

4.4.2.2. Market Share Comparison, By Region

4.4.2.3. Y-o-Y growth Comparison, By Region

4.4.4.  Market Size and Forecast, 2012-2026

4.4.4.1. Revenue (US$ Mn) Comparison, By Region

4.4.4.2. Market Share Comparison, By Region

4.4.4.3. Y-o-Y growth Comparison, By Region

5. North America Rare Inflammatory Disease Treatment Market Size and Forecast, 2012-2026

5.1. North America Outlook 

5.2. North America Parent Market Outlook 

5.3. North America Target Market Outlook 

5.4. Revenue (US$ Mn) Comparison, By Country 

5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026

5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026

5.5. Revenue (US$ Mn) Comparison, By Indication 

5.6. Revenue (US$ Mn) Comparison, By Drug Class 

5.7. Revenue (US$ Mn) Comparison, By Mode of Administration 

5.8. Revenue (US$ Mn) Comparison, By Distribution Channel 

6. Latin America Rare Inflammatory Disease Treatment Market Size and Forecast, 2012-2026

6.1. Latin America Outlook 

6.2. Latin America Parent Market Outlook 

6.3. Latin America Target Market Outlook 

6.4. Revenue (US$ Mn) Comparison, By Country 

6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026

6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026

6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026

6.5. Revenue (US$ Mn) Comparison, By Indication 

6.6. Revenue (US$ Mn) Comparison, By Drug Class 

6.7. Revenue (US$ Mn) Comparison, By Mode of Administration 

6.8. Revenue (US$ Mn) Comparison, By Distribution Channel 

7. Europe Rare Inflammatory Disease Treatment Market Size and Forecast, 2012-2026

7.1. Europe Outlook 

7.2. Europe Parent Market Outlook 

7.3. Europe Target Market Outlook 

7.4. Revenue (US$ Mn) Comparison, By Country 

7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026

7.4.2. U.K. Market Size and Forecast (US$ Mn), 2012-2026

7.4.3. Spain Market Size and Forecast (US$ Mn), 2012-2026

7.4.4. France Market Size and Forecast (US$ Mn), 2012-2026

7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026

7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026

7.5. Revenue (US$ Mn) Comparison, By Indication 

7.6. Revenue (US$ Mn) Comparison, By Drug Class 

7.7. Revenue (US$ Mn) Comparison, By Mode of Administration 

7.8. Revenue (US$ Mn) Comparison, By Distribution Channel 

8. Japan Rare Inflammatory Disease Treatment Market Size and Forecast, 2012-2026

8.1. Japan Outlook 

8.2. Japan Parent Market Outlook 

8.3. Japan Target Market Outlook 

8.4. Japan Market Size and Forecast (US$ Mn), 2012-2026

8.5. Revenue (US$ Mn) Comparison, By Indication 

8.6. Revenue (US$ Mn) Comparison, By Drug Class 

8.7. Revenue (US$ Mn) Comparison, By Mode of Administration 

8.8. Revenue (US$ Mn) Comparison, By Distribution Channel 

9. APEJ Rare Inflammatory Disease Treatment Market Size and Forecast, 2012-2026

9.1. APEJ Outlook 

9.2. APEJ Parent Market Outlook 

9.3. APEJ Target Market Outlook 

9.4. Revenue (US$ Mn) Comparison, By Country 

9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026

9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026

9.4.3. Malaysia Market Size and Forecast (US$ Mn), 2012-2026

9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026

9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026

9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026

9.5. Revenue (US$ Mn) Comparison, By Indication 

9.6. Revenue (US$ Mn) Comparison, By Drug Class 

9.7. Revenue (US$ Mn) Comparison, By Mode of Administration 

9.8. Revenue (US$ Mn) Comparison, By Distribution Channel 

10. MEA Rare Inflammatory Disease Treatment Market Size and Forecast, 2012-2026

10.1. MEA Outlook 

10.2. MEA Parent Market Outlook 

10.3. MEA Target Market Outlook 

10.4. Revenue (US$ Mn) Comparison, By Country 

10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026

10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026

10.4.3. Israel Market Size and Forecast (US$ Mn), 2012-2026

10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026

10.5. Revenue (US$ Mn) Comparison, By Indication 

10.6. Revenue (US$ Mn) Comparison, By Drug Class 

10.7. Revenue (US$ Mn) Comparison, By Mode of Administration 

10.8. Revenue (US$ Mn) Comparison, By Distribution Channel 

11. Global Rare Inflammatory Disease Treatment Market Company Share, Competition Landscape and Company Profiles

11.1. Global Rare Inflammatory Disease Treatment Market- Company Share Analysis

11.2. Global Rare Inflammatory Disease Treatment Market - Competition Landscape

11.3. Global Rare Inflammatory Disease Treatment Market - Company Profiles

11.3.1. Pfizer, Inc.

11.3.2. Novartis AG

11.3.3. Allergan Plc

11.3.4. Abbvie, Inc.

11.3.5. Valeant Pharmaceuticals International, Inc.

11.3.6. Abbott Laboratories

11.3.7. Johnson & Johnson

11.3.8. Regeneron Pharmaceuticals, Inc.

11.3.9. Mallinckrodt Plc

11.3.10. Swedish Orphan Biovitrum AB

12. Global Rare Inflammatory Disease Treatment Market - Key Takeaways

13. Research Methodology

14. Disclaimer

Rare Inflammatory Disease Treatment Market Reports - List of Tables

TABLE 1 Global Rare Inflammatory Disease Treatment Market Value (US$ Mn), 2012-2017

TABLE 2 Global Rare Inflammatory Disease Treatment Market Value (US$ Mn), 2018-2026

TABLE 3 Global Rare Inflammatory Disease Treatment Market Value (US$ Mn) and Y-o-Y, 2017-2026

TABLE 4 Global Ulcerative Colitis Segment Value (US$ Mn), By Region 2012-2017

TABLE 5 Global Ulcerative Colitis Segment Value (US$ Mn), By Region 2018-2026

TABLE 6 Global Ulcerative Colitis Segment Market Share, By Region 2012-2017

TABLE 7 Global Ulcerative Colitis Segment Market Share, By Region 2018-2026

TABLE 8 Global Ulcerative Colitis Segment Y-o-Y, By Region 2017-2026

TABLE 9 Global Juvenile Rheumatoid Arthritis Segment Value (US$ Mn), By Region 2012-2017

TABLE 10 Global Juvenile Rheumatoid Arthritis Segment Value (US$ Mn), By Region 2018-2026

TABLE 11 Global Juvenile Rheumatoid Arthritis Segment Market Share, By Region 2012-2017

TABLE 12 Global Juvenile Rheumatoid Arthritis Segment Market Share, By Region 2018-2026

TABLE 13 Global Juvenile Rheumatoid Arthritis Segment Y-o-Y, By Region 2017-2026

TABLE 14 Global Psoriatic Arthritis Segment Value (US$ Mn), By Region 2012-2017

TABLE 15 Global Psoriatic Arthritis Segment Value (US$ Mn), By Region 2018-2026

TABLE 16 Global Psoriatic Arthritis Segment Market Share, By Region 2012-2017

TABLE 17 Global Psoriatic Arthritis Segment Market Share, By Region 2018-2026

TABLE 18 Global Psoriatic Arthritis Segment Y-o-Y, By Region 2017-2026

TABLE 19 Global Other Indications Segment Value (US$ Mn), By Region 2012-2017

TABLE 20 Global Other Indications Segment Value (US$ Mn), By Region 2018-2026

TABLE 21 Global Other Indications Segment Market Share, By Region 2012-2017

TABLE 22 Global Other Indications Segment Market Share, By Region 2018-2026

TABLE 23 Global Other Indications Segment Y-o-Y, By Region 2017-2026

TABLE 24 Global Biologics Segment Value (US$ Mn), By Region 2012-2017

TABLE 25 Global Biologics Segment Value (US$ Mn), By Region 2018-2026

TABLE 26 Global Biologics Segment Market Share, By Region 2012-2017

TABLE 27 Global Biologics Segment Market Share, By Region 2018-2026

TABLE 28 Global Biologics Segment Y-o-Y, By Region 2017-2026

TABLE 29 Global Organic Compounds Segment Value (US$ Mn), By Region 2012-2017

TABLE 30 Global Organic Compounds Segment Value (US$ Mn), By Region 2018-2026

TABLE 31 Global Organic Compounds Segment Market Share, By Region 2012-2017

TABLE 32 Global Organic Compounds Segment Market Share, By Region 2018-2026

TABLE 33 Global Organic Compounds Segment Y-o-Y, By Region 2017-2026

TABLE 34 Global Injectables Segment Value (US$ Mn), By Region 2012-2017

TABLE 35 Global Injectables Segment Value (US$ Mn), By Region 2018-2026

TABLE 36 Global Injectables Segment Market Share, By Region 2012-2017

TABLE 37 Global Injectables Segment Market Share, By Region 2018-2026

TABLE 38 Global Injectables Segment Y-o-Y, By Region 2017-2026

TABLE 39 Global Oral Segment Value (US$ Mn), By Region 2012-2017

TABLE 40 Global Oral Segment Value (US$ Mn), By Region 2018-2026

TABLE 41 Global Oral Segment Market Share, By Region 2012-2017

TABLE 42 Global Oral Segment Market Share, By Region 2018-2026

TABLE 43 Global Oral Segment Y-o-Y, By Region 2017-2026

TABLE 44 Global Others Segment Value (US$ Mn), By Region 2012-2017

TABLE 45 Global Others Segment Value (US$ Mn), By Region 2018-2026

TABLE 46 Global Others Segment Market Share, By Region 2012-2017

TABLE 47 Global Others Segment Market Share, By Region 2018-2026

TABLE 48 Global Others Segment Y-o-Y, By Region 2017-2026

TABLE 49 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017

TABLE 50 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026

TABLE 51 Global Hospital Pharmacies Segment Market Share, By Region 2012-2017

TABLE 52 Global Hospital Pharmacies Segment Market Share, By Region 2018-2026

TABLE 53 Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026

TABLE 54 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2017

TABLE 55 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2026

TABLE 56 Global Retail Pharmacies Segment Market Share, By Region 2012-2017

TABLE 57 Global Retail Pharmacies Segment Market Share, By Region 2018-2026

TABLE 58 Global Retail Pharmacies Segment Y-o-Y, By Region 2017-2026

TABLE 59 Global Online Pharmacies Segment Value (US$ Mn), By Region 2012-2017

TABLE 60 Global Online Pharmacies Segment Value (US$ Mn), By Region 2018-2026

TABLE 61 Global Online Pharmacies Segment Market Share, By Region 2012-2017

TABLE 62 Global Online Pharmacies Segment Market Share, By Region 2018-2026

TABLE 63 Global Online Pharmacies Segment Y-o-Y, By Region 2017-2026

TABLE 64 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2012-2017

TABLE 65 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2018-2026

TABLE 66 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2012-2017

TABLE 67 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2018-2026

TABLE 68 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2012-2017

TABLE 69 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2018-2026

TABLE 70 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017

TABLE 71 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026

TABLE 72 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017

TABLE 73 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026

TABLE 74 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2012-2017

TABLE 75 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2018-2026

TABLE 76 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2012-2017

TABLE 77 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2018-2026

TABLE 78 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2012-2017

TABLE 79 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2018-2026

TABLE 80 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017

TABLE 81 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026

TABLE 82 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017

TABLE 83 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026

TABLE 84 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2012-2017

TABLE 85 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2018-2026

TABLE 86 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2012-2017

TABLE 87 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2018-2026

TABLE 88 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2012-2017

TABLE 89 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2018-2026

TABLE 90 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017

TABLE 91 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026

TABLE 92 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017

TABLE 93 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026

TABLE 94 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2012-2017

TABLE 95 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2018-2026

TABLE 96 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2012-2017

TABLE 97 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2018-2026

TABLE 98 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2012-2017

TABLE 99 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2018-2026

TABLE 100 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017

TABLE 101 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026

TABLE 102 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017

TABLE 103 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026

TABLE 104 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2012-2017

TABLE 105 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2018-2026

TABLE 106 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2012-2017

TABLE 107 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2018-2026

TABLE 108 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2012-2017

TABLE 109 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2018-2026

TABLE 110 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017

TABLE 111 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026

TABLE 112 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017

TABLE 113 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026

TABLE 114 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2012-2017

TABLE 115 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2018-2026

TABLE 116 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2012-2017

TABLE 117 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2018-2026

TABLE 118 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2012-2017

TABLE 119 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2018-2026

TABLE 120 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017

TABLE 121 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026

TABLE 122 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017

TABLE 123 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026

Rare Inflammatory Disease Treatment Market Reports - List of Figures

FIG. 1 Global Rare Inflammatory Disease Treatment Market Value (US$ Mn), 2012-2017

FIG. 2 Global Rare Inflammatory Disease Treatment Market Value (US$ Mn) Forecast, 2018-2026

FIG. 3 Global Rare Inflammatory Disease Treatment Market Value (US$ Mn) and Y-o-Y, 2017-2026

FIG. 4 Global Ulcerative Colitis Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 5 Global Ulcerative Colitis Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 6 Global Ulcerative Colitis Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 7 Global Juvenile Rheumatoid Arthritis Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 8 Global Juvenile Rheumatoid Arthritis Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 9 Global Juvenile Rheumatoid Arthritis Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 10 Global Psoriatic Arthritis Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 11 Global Psoriatic Arthritis Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 12 Global Psoriatic Arthritis Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 13 Global Other Indications Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 14 Global Other Indications Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 15 Global Other Indications Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 16 Global Biologics Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 17 Global Biologics Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 18 Global Biologics Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 19 Global Organic Compounds Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 20 Global Organic Compounds Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 21 Global Organic Compounds Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 22 Global Injectables Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 23 Global Injectables Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 24 Global Injectables Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 25 Global Oral Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 26 Global Oral Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 27 Global Oral Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 28 Global Others Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 29 Global Others Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 30 Global Others Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 31 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 32 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 33 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 34 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 35 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 36 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 37 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 38 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 39 Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 40 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2012-2017

FIG. 41 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2018-2026

FIG. 42 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2012-2017

FIG. 43 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2018-2026

FIG. 44 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2012-2017

FIG. 45 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2018-2026

FIG. 46 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017

FIG. 47 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026

FIG. 48 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017

FIG. 49 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026

FIG. 50 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2012-2017

FIG. 51 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2018-2026

FIG. 52 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2012-2017

FIG. 53 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2018-2026

FIG. 54 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2012-2017

FIG. 55 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2018-2026

FIG. 56 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017

FIG. 57 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026

FIG. 58 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017

FIG. 59 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026

FIG. 60 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2012-2017

FIG. 61 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2018-2026

FIG. 62 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2012-2017

FIG. 63 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2018-2026

FIG. 64 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2012-2017

FIG. 65 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2018-2026

FIG. 66 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017

FIG. 67 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026

FIG. 68 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017

FIG. 69 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026

FIG. 70 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2012-2017

FIG. 71 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2018-2026

FIG. 72 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2012-2017

FIG. 73 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2018-2026

FIG. 74 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017

FIG. 75 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2018-2026

FIG. 76 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017

FIG. 77 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026

FIG. 78 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017

FIG. 79 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026

FIG. 80 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2012-2017

FIG. 81 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2018-2026

FIG. 82 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2012-2017

FIG. 83 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2018-2026

FIG. 84 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2012-2017

FIG. 85 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2018-2026

FIG. 86 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017

FIG. 87 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026

FIG. 88 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017

FIG. 89 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026

FIG. 90 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2012-2017

FIG. 91 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2018-2026

FIG. 92 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2012-2017

FIG. 93 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2018-2026

FIG. 94 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2012-2017

FIG. 95 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2018-2026

FIG. 96 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017

FIG. 97 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026

FIG. 98 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017

FIG. 99 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026